SG11201706593SA - Methods for producing virus for vaccine production - Google Patents
Methods for producing virus for vaccine productionInfo
- Publication number
- SG11201706593SA SG11201706593SA SG11201706593SA SG11201706593SA SG11201706593SA SG 11201706593S A SG11201706593S A SG 11201706593SA SG 11201706593S A SG11201706593S A SG 11201706593SA SG 11201706593S A SG11201706593S A SG 11201706593SA SG 11201706593S A SG11201706593S A SG 11201706593SA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- vaccine production
- producing virus
- virus
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32351—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32361—Methods of inactivation or attenuation
- C12N2770/32363—Methods of inactivation or attenuation by chemical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562116361P | 2015-02-13 | 2015-02-13 | |
PCT/US2016/017784 WO2016130940A1 (fr) | 2015-02-13 | 2016-02-12 | Procédés de production de virus pour produire des vaccins |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201706593SA true SG11201706593SA (en) | 2017-09-28 |
Family
ID=56615015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201706593SA SG11201706593SA (en) | 2015-02-13 | 2016-02-12 | Methods for producing virus for vaccine production |
Country Status (12)
Country | Link |
---|---|
US (1) | US20180195048A1 (fr) |
EP (1) | EP3256571B1 (fr) |
JP (1) | JP6723253B2 (fr) |
KR (1) | KR20170116140A (fr) |
CN (2) | CN114107221A (fr) |
AU (2) | AU2016219122A1 (fr) |
CA (1) | CA2975881A1 (fr) |
HK (1) | HK1248759A1 (fr) |
MA (1) | MA41506A (fr) |
PH (1) | PH12017501445A1 (fr) |
SG (1) | SG11201706593SA (fr) |
WO (1) | WO2016130940A1 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3122866B1 (fr) | 2014-03-25 | 2019-11-20 | Terumo BCT, Inc. | Remplacement passif de milieu |
WO2017004592A1 (fr) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Croissance cellulaire à l'aide de stimuli mécaniques |
JP7034949B2 (ja) | 2016-05-25 | 2022-03-14 | テルモ ビーシーティー、インコーポレーテッド | 細胞の増殖 |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
BR112019004187A2 (pt) * | 2016-09-01 | 2019-06-25 | Takeda Pharmaceuticals Co | método para produzir um vírus enterovírus c, e, vírus enterovírus c. |
BE1024733B1 (fr) | 2016-11-09 | 2018-06-14 | Univercells Sa | Matrice de croissance cellulaire |
KR102091372B1 (ko) * | 2017-02-28 | 2020-05-27 | 대한민국 | 엔테로바이러스 71형 불활화 백신 및 이의 용도 |
CN110612344B (zh) | 2017-03-31 | 2023-09-12 | 泰尔茂比司特公司 | 细胞扩增 |
US20200318060A1 (en) * | 2017-09-27 | 2020-10-08 | Univercells S.A. | System and method for the production of biomolecules such as viral vaccines |
US20210130760A1 (en) | 2017-12-20 | 2021-05-06 | Univercells Technologies S.A. | Bioreactor and related methods |
US20200248122A1 (en) | 2019-02-05 | 2020-08-06 | Corning Incorporated | Packed-bed bioreactor systems and methods of using the same |
US20220098555A1 (en) | 2019-02-15 | 2022-03-31 | Ology Bioservices, Inc. | Method for virus production |
US11118151B2 (en) | 2019-11-05 | 2021-09-14 | Corning Incorporated | Fixed bed bioreactor and methods of using the same |
KR102696955B1 (ko) * | 2019-11-27 | 2024-08-19 | 에스케이바이오사이언스(주) | 무혈청 배지에서 부유배양이 가능한 신규한 Vero 세포주, 이의 제조 방법 및 상기 신규 세포주를 이용한 백신용 바이러스 제조 방법 |
EP4157456A4 (fr) * | 2020-05-29 | 2024-06-26 | Oncorus, Inc. | Réplicons d'arn encapsulés et procédés d'utilisation |
CN111849870B (zh) * | 2020-08-07 | 2021-07-23 | 成都柏奥特克生物科技股份有限公司 | 无血清Vero细胞固定床生物反应器高密度培养工艺 |
CN114990075B (zh) * | 2022-04-20 | 2023-07-14 | 中国医学科学院医学生物学研究所 | 一株可适用于人用疫苗细胞基质培养的柯萨奇病毒a组10型疫苗株及其应用 |
CN114807060B (zh) * | 2022-06-23 | 2022-09-30 | 北京民海生物科技有限公司 | 柯萨奇病毒a6型毒株及其免疫原性组合物和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2327103T3 (es) * | 2000-09-25 | 2009-10-26 | Polymun Scientific Immunbiologische Forschung Gmbh | Vacuna viva de influenzavirus y procedimiento de fabricacion. |
US9051361B2 (en) * | 2010-08-17 | 2015-06-09 | National Health Research Institutes | Immunogenic compositions and uses thereof |
JP6117379B2 (ja) * | 2013-01-18 | 2017-04-19 | テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド | エンテロウイルス71の低温適応温度感受性株および低温適応温度感受性ウイルス株を発展させるプロセス |
CN103215233B (zh) * | 2013-04-03 | 2015-03-25 | 浙江普康生物技术股份有限公司 | 用生物反应器扩增肠道病毒71型的优化工艺方法 |
-
2016
- 2016-02-11 MA MA041506A patent/MA41506A/fr unknown
- 2016-02-12 CN CN202111316202.3A patent/CN114107221A/zh active Pending
- 2016-02-12 SG SG11201706593SA patent/SG11201706593SA/en unknown
- 2016-02-12 KR KR1020177025598A patent/KR20170116140A/ko not_active Application Discontinuation
- 2016-02-12 CN CN201680015584.7A patent/CN107532150A/zh active Pending
- 2016-02-12 EP EP16749976.3A patent/EP3256571B1/fr active Active
- 2016-02-12 CA CA2975881A patent/CA2975881A1/fr not_active Abandoned
- 2016-02-12 WO PCT/US2016/017784 patent/WO2016130940A1/fr active Application Filing
- 2016-02-12 US US15/550,718 patent/US20180195048A1/en not_active Abandoned
- 2016-02-12 AU AU2016219122A patent/AU2016219122A1/en not_active Abandoned
- 2016-02-12 JP JP2017542081A patent/JP6723253B2/ja not_active Expired - Fee Related
-
2017
- 2017-08-10 PH PH12017501445A patent/PH12017501445A1/en unknown
-
2018
- 2018-06-28 HK HK18108353.4A patent/HK1248759A1/zh unknown
-
2022
- 2022-03-28 AU AU2022202087A patent/AU2022202087A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP3256571A4 (fr) | 2018-07-25 |
CA2975881A1 (fr) | 2016-08-18 |
WO2016130940A1 (fr) | 2016-08-18 |
JP2018506283A (ja) | 2018-03-08 |
HK1248759A1 (zh) | 2018-10-19 |
PH12017501445A1 (en) | 2018-01-15 |
MA41506A (fr) | 2017-12-19 |
EP3256571B1 (fr) | 2022-03-30 |
EP3256571A1 (fr) | 2017-12-20 |
AU2022202087A1 (en) | 2022-04-14 |
CN107532150A (zh) | 2018-01-02 |
JP6723253B2 (ja) | 2020-07-15 |
AU2016219122A1 (en) | 2017-09-07 |
CN114107221A (zh) | 2022-03-01 |
KR20170116140A (ko) | 2017-10-18 |
US20180195048A1 (en) | 2018-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1248759A1 (zh) | 用於產生製備疫苗的病毒的方法 | |
EP3506939A4 (fr) | Procédés de production de virus pour produire des vaccins | |
ZA201708142B (en) | Process for preparing 4-amino-pyridazines | |
SG10201509454YA (en) | Wafer producing method | |
PL3155129T3 (pl) | Sposób zwiększania wytwarzania RNA | |
HUE059158T2 (hu) | Eljárás pridopidin elõállítására | |
SG10201509471YA (en) | Wafer producing method | |
HUE047041T2 (hu) | Eljárás poliéteraminok elõállítására | |
EP3333266C0 (fr) | Procédé de production sélénoéine | |
ZA201508687B (en) | Process for producing composites | |
RS65534B1 (sr) | Postupak za izradu betonskih elemenata | |
SG10201509458RA (en) | Wafer producing method | |
IL252173A0 (en) | Methods for the production of methyl dichlorophosphane | |
IL253877A0 (en) | Process for preparing 3-chloro-2-vinylphenylsulfonates | |
SG11201701326YA (en) | Method for producing oligosilane | |
IL247500A0 (en) | A process for creating young chickens | |
HK1249098A1 (zh) | 用於生產氟美他酚的方法 | |
IL258981A (en) | Methods for the production of proteins | |
HUE054626T2 (hu) | Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására | |
HK1256031A1 (zh) | 新的4-苯並偶氮寧衍生物的製造方法 | |
PL3138556T3 (pl) | Sposób wytwarzania liposomu | |
IL243795A0 (en) | A process for the preparation of a quinazoline derivative | |
GB201503953D0 (en) | Process for producing a denture | |
IL255093A0 (en) | A method for the production of levoglucosenon | |
IL249283B (en) | Process for the preparation of 3-chloro-2-vinylphenol |